Marco Matucci‐Cerinic

Research interests

Publications

• Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

  The Lancet Respiratory Medicine · 2020 · https://doi.org/10.1016/s2213-2600(20)30318-0

• Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

  The Lancet Respiratory Medicine · 2020 · https://doi.org/10.1016/s2213-2600(20)30318-0

• COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs

  TURKISH JOURNAL OF MEDICAL SCIENCES · 2020 · 10.3906/sag-2004-168

• Mapping and predicting mortality from systemic sclerosis

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2017-211448

• Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease

  European Heart Journal · 2017 · https://doi.org/10.1093/eurheartj/ehx321

• Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

  Journal of Scleroderma and Related Disorders · 2017 · https://doi.org/10.5301/jsrd.5000231

• Update of EULAR recommendations for the treatment of systemic sclerosis

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209909

• Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

  JAMA · 2014 · 10.1001/jama.2014.6368

• Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

  Annals of the Rheumatic Diseases · 2014 · https://doi.org/10.1136/annrheumdis-2013-204522

• Review: Evidence That Systemic Sclerosis Is a Vascular Disease

  Arthritis & Rheumatism · 2013 · 10.1002/art.37988

• 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

  Annals of the Rheumatic Diseases · 2013 · https://doi.org/10.1136/annrheumdis-2013-204424

• Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis

  Annals of the Rheumatic Diseases · 2013 · https://doi.org/10.1136/annrheumdis-2013-203716

• 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

  Arthritis & Rheumatism · 2013 · https://doi.org/10.1002/art.38098

• Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study

  Arthritis Care & Research · 2012 · https://doi.org/10.1002/acr.21747

• American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

  Arthritis & Rheumatism · 2011 · https://doi.org/10.1002/art.30129

• Genome-Wide Scan Identifies TNIP1, PSORS1C1, and RHOB as Novel Risk Loci for Systemic Sclerosis

  PLoS Genetics · 2011 · https://doi.org/10.1371/journal.pgen.1002091

• Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

  Annals of the Rheumatic Diseases · 2011 · https://doi.org/10.1136/ard.2010.149419

• American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

  Annals of the Rheumatic Diseases · 2011 · 10.1136/ard.2011.149765

• Involvement of functional autoantibodies against vascular receptors in systemic sclerosis

  Annals of the Rheumatic Diseases · 2010 · https://doi.org/10.1136/ard.2010.135772

• Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

  Annals of the Rheumatic Diseases · 2010 · https://doi.org/10.1136/ard.2010.136929

• Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

  Annals of the Rheumatic Diseases · 2010 · 10.1136/ard.2010.130658

• Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies

  The Journal of Rheumatology · 2010 · 10.3899/jrheum.100245

• EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

  Annals of the Rheumatic Diseases · 2009 · https://doi.org/10.1136/ard.2008.096677

• Prevalence of Fibromyalgia: A Survey in Five European Countries

  Seminars in Arthritis and Rheumatism · 2009 · 10.1016/j.semarthrit.2008.12.003

• Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

  Annals of the Rheumatic Diseases · 2007 · https://doi.org/10.1136/ard.2006.062901

• Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases

  Circulation · 2005 · https://doi.org/10.1161/circulationaha.104.507996

• Mortality in systemic sclerosis: An international meta-analysis of individual patient data

  The American Journal of Medicine · 2005 · 10.1016/j.amjmed.2004.04.031

• Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis

  Circulation Research · 2004 · https://doi.org/10.1161/01.res.0000134644.89917.96

• Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

  Arthritis Research & Therapy · 2002 · https://doi.org/10.1186/ar596

Current projects

No projects listed.